151
Participants
Start Date
August 31, 2011
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
florbetapir F 18
No study drug will be administered in this study - scans previously acquired in in Study A05(NCT00702143) and A07(NCT00857415) will be read
Lead Sponsor
Avid Radiopharmaceuticals
INDUSTRY